Cyberdyne: Announcement on the new product Medical Vital Sensor “Cyvis M100”
Cyberdyne: Notice regarding the new product “Medical Vital Sensor Cyvis M100”
Cyberdyne: Notice on decision to sign business consignment agreement concerning SIP
Cyberdyne: Notice of conclusion of an outsourcing agreement relating to the Strategic Innovation Creation Program (SIP) business
Cyberdyne: Notice of contract with the Malaysian Social Security Organization for Cybernics products.
Cyberdyne: Signed an agreement with the Social Security Organization, a Malaysian government agency, to introduce Cybernics products
Cyberdyne: Notice of Cybernics Product Orders in Ukraine
Cyberdyne: Notice regarding receipt of orders for Cybernics products for emergency recovery and reconstruction in Ukraine
Cyberdyne: Consolidated Financial Results (Tanshin) for the Six months ended September 30, 2025 (Based on IFRS)
Cyberdyne: Consolidated financial statements (Tan Shin) for the three months ending June 30, 2025 (based on IFRS).
Cyberdyne: Regarding matters related to dominant shareholders.
Cyberdyne: Explanatory material about business plans and growth potential.
Cyberdyne: Announcements of individual stocks regarding the selection of projects to support research and development of growing small and medium-sized enterprises.
Cyberdyne: Announcements of individual stocks: Notice of adoption of the Growth-Oriented Small and Medium-sized Enterprise Research and Development Support Program (Go-Tech Program) in FY 2024.
Cyberdyne: Independent Company Executives Declaration
Cyberdyne: Preparations are underway for Malaysia's National Neurorobotics Cybernics Rehabilitation Centre
Cyberdyne: Preparations for the Malaysian National Neurorobotics Cybernics Rehabilitation Center are progressing ~ Minister of Human Resources visits the company and expresses intention to introduce HAL on a large scale ~
Cyberdyne: The US FDA approved for the first time in the world a small model of medical HAL and expanded indications for cerebral palsy
Cyberdyne: Notifications about financial income, financial expenses, extraordinary losses, and differences in financial results between the previous fiscal year and the current fiscal year
Cyberdyne: The US FDA approved the world's first small model of medical HAL and expansion of adaptation to cerebral palsy